기사 (10,121건) 리스트형 웹진형 타일형 ATFX's MT4 Trading Volume Ranked Fifth Globally in the Second Quarter KUALA LUMPUR, Malaysia , Sept. 11, 2023 /PRNewswire/ --... Global Times: China's technology, standards and wisdom bring tremendous changes to Central Asia's socio-economic development, reshape geopolitical landscape BEIJING, Sept. 11, 2023 /PRNewswire/ -- In history, Tas... Global Times: From Luban Workshop to 'Silk Road' University, China trains professional personnel for Central Asia BEIJING, Sept. 11, 2023 /PRNewswire/ -- "To have such a... Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer Can we really make a difference in reducing the heartbreak of millions of miscarriages each year? Can we really make a difference in reducing the heartbreak of millions of miscarriages each year? RBSL, HUBER+SUHNER와 케이블 하네스 납품 계약 체결 RBSL, HUBER+SUHNER와 케이블 하네스 납품 계약 체결 Delta Singapore Showcases Smart Green Building Automation, HVAC and Energy Solutions at MARVEX 2023 Delta Singapore Showcases Smart Green Building Automation, HVAC and Energy Solutions at MARVEX 2023 Global Times: Fujian-based 'Silk Road Maritime' association expands shipping routes to 116, reaching 131 harbors in the world BEIJING, Sept. 11, 2023 /PRNewswire/ -- East China's Fu... PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells 페프로민 바이오, 첫 접종 집단의 완료 및 두 번째 PMB-CT01(BAFFR-CAR T세포)의 B세포 비호지킨 림프종(B-NHL) 1상 임상 시험 접종 집단의 시작을 발표하다 페프로민 바이오, 첫 접종 집단의 완료 및 두 번째 PMB-CT01(BAFFR-CAR T세포)의 B세포 비호지킨 림프종(B-NHL) 1상 임상 시험 접종 집단의 시작을 발표하다 Microland와 Serco AsPac, 디지털 전환을 위한 전략적 파트너십 발표 Microland와 Serco AsPac, 디지털 전환을 위한 전략적 파트너십 발표 처음처음이전이전이전501502503504505506507508509510다음다음다음끝끝